Abstract: A display panel, a display device as well as a control method and preparation method thereof. The display panel comprises: a filter provided with a light transmission part and a non-light transmission part corresponding to each pixel; a micro mirror array assembly comprising a substrate and a micro mirror array arranged on the substrate, the micro mirror array being provided with at least one micro mirror corresponding to each pixel; wherein mirror surfaces of the micro mirrors of the micro mirror array are arranged to substantially face towards the filter so as to enable light rays reflected by the micro mirrors to be emitted to the filter, and rotation of each of the micro mirrors on the substrate is controlled so as to enable the reflected light rays to be controllably reflected to the light transmission part and/or the non-light transmission part of the corresponding pixel.

Abstract: A testing method and a testing apparatus for splicing screens (1, 2, 3, 4) are provided. The method includes: outputting an image signal to a display screen, wherein the display screen includes a plurality of splicing screens (1, 2, 3, 4), the image signal includes a plurality of testing sub pictures, the testing sub pictures are arranged correspondingly to the splicing screens (1, 2, 3, 4) so as to enable the splicing screens (1, 2, 3, 4) to display the corresponding testing sub pictures, and the testing sub pictures include testing contents (5, 6, 7, 8, 9, 10, 11, 12); and testing the splicing screens (1, 2, 3, 4) through the testing contents (5, 6, 7, 8, 9, 10, 11, 12). Testing on the splicing screens (1, 2, 3, 4) is achieved, and a testing result can be used for regulating the splicing screens (1, 2, 3, 4), so that defects generated in the displaying process of the splicing screens (1, 2, 3, 4) are reduced.

Abstract: An embodiment of the present invention disclose a flexible display device, comprising: a housing; a supporting member, disposed inside the housing; a flexible display screen, having a first end and a second end opposite to each other, the first end being connected with the supporting member and being able to rotate around an axis; and at least one bracket rotationally connected with the housing and having a slot is arranged thereon, wherein, a side edge portion of the flexible display screen located between the first end and the second end is capable of moving along a direction of the slot under guidance of the bracket.

Abstract: The present invention relates to the identification of genetic markers patients with high risk B-precursor acute lymphoblastic leukemia (B-ALL) and associated methods and their relationship to therapeutic outcome. The present invention also relates to diagnostic, prognostic and related methods using these genetic markers, as well as kits which provide microchips and/or immunoreagents for performing analysis on leukemia patients.

Abstract: The present invention relates to the identification of genetic markers patients with leukemia, especially including acute lymphoblastic leukemia (ALL) at high risk for relapse, especially high risk B-precursor acute lymphoblastic leukemia (B-ALL) and associated methods and their relationship to therapeutic outcome. The present invention also relates to diagnostic, prognostic and related methods using these genetic markers, as well as kits which provide microchips and/or immunoreagents for performing analysis on leukemia patients.

Abstract: The present invention relates to the identification of genetic markers patients with high risk B-precursor acute lymphoblastic leukemia (B-ALL) and associated methods and their relationship to therapeutic outcome. The present invention also relates to diagnostic, prognostic and related methods using these genetic markers, as well as kits which provide microchips and/or immunoreagents for performing analysis on leukemia patients.

Abstract: Genes and gene expression profiles useful for predicting outcome, risk classification, cytogenetics and/or etiology in pediatric acute lymphoblastic leukemia (ALL). OPAL1 is a novel gene associated with outcome and, along with other newly identified genes, represent a novel therapeutic targets.

Abstract: Genes and gene expression profiles useful for predicting outcome, risk classification, cytogenetics and/or etiology in pediatric acute lymphoblastic leukemia (ALL). OPAL1 is a novel gene associated with outcome and, along with other newly identified genes, represent a novel therapeutic targets.